Dependent: Business travel reduction and eco-fleet transition Global internal travel policy applies criteria automatically through booking tool based on duration. Encouragement of virtual meetings with high-definition video-conferencing equipment. Car fleet policy reviewed 2023 to cover EV charging installation at home for employees opting for electric vehicles. Eco-driving courses, target 80% eco-fleet by 2030 (currently 50%). Sales force CO2e cut 50% vs 2019.
▾ expand
Living wage commitment achieved In 2024, all 104 living wage gaps identified in 2023 were addressed, achieving full alignment with living wage standards across all direct employees by June 2024.
▾ expand
Cancer & Work: Acting Together global program launched Launched worldwide in 2024, 360° approach addressing employees impacted by cancer/critical illness. Employees diagnosed maintain job, salary and benefits for up to 12 months globally.
▾ expand
Primary: Energy efficiency and decarbonization of Scope 1&2 Scope 1&2 emissions cut 47% from 2019 to 2024 (708 to 374 ktCO2e). Approach combines energy efficiency (ISO 50001 certified, 15% energy consumption reduction target by 2025 vs 2021) and energy decarbonization (renewable electricity, biomethane). Refrigerant emissions reduced 41% since 2019 (-9,300 tCO2e). Eco-car fleet: 50% of fleet meets criteria, CO2e from sales force cut 50% vs 2019, target 80% eco-fleet by 2030.
▾ expand
Primary: Eco-design and product reformulation Commitment to eco-design all new products by 2025. By 2027, no plastic in vaccine syringe blister packs (PVC-free packaging). 27 LCAs completed using PEF EF 3.0 methodology. Eco-design substances-of-concern list integrated into LCA tool. Solvent Guide promotes less hazardous solvents; 58% of solvents regenerated and reintroduced in industrial process in 2024.
▾ expand
Dependent: Sustainable transport: shift from air to sea freight To decrease emissions from international transport network, Sanofi uses less air transport and more sea/road/rail shipment. Maximizing sea transport for vaccine shipments (excluding flu vaccines) from France to 13 countries (Australia, Japan, Malaysia, South Korea, Brazil). Developing rail for intra-European and France-China deliveries, experimenting with electric/natural gas vehicles, designing packaging to reduce volume, grouping shipments to pool transport.
▾ expand
Opella divestiture exclusive negotiations announced On October 21, 2024, Sanofi and Clayton, Dubilier & Rice (CD&R) entered exclusive negotiations for Proposed Opella Transaction. Triggered reclassification of Opella as discontinued operation under IFRS 5. Sanofi retains ~50% indirect stake.
▾ expand
Turnover calculation methodology aligned with CSRD In 2024, turnover calculation changed to align with CSRD requirements. 2024 turnover = departures of permanent contracts / average of 2023 and 2024 year-end permanent headcount. Previously included hires + terminations / 2.
▾ expand
ISO 50001 and ISO 14001 certifications maintained Sanofi's Energy management system certified to ISO 50001:2018 and HSE management system certified to ISO 14001:2015 for research, development, manufacturing, distribution centers and related support functions.
▾ expand
100% renewable electricity by 2030 via PPAs, EACs, and on-site solar Sanofi joined RE100 in September 2020 with commitment to 100% renewable electricity by 2030 (80% by 2025). Strategy combines: (i) on-site solar PV self-generation (18.8 GWh in 2024, up from 0.5 GWh end-2021); (ii) Power Purchase Agreements - 11 PPAs signed in 2024 in France for 238.5 GWh/year covering 50% of French electricity needs, plus PPA in Mexico; (iii) Energy Attribute Certificates including Guarantees of Origin, I-RECs, J-Credit in Japan; (iv) long-term biomethane contract in France (2024-2030) for 210 GWh/year. Renewable electricity reached 85% of consumption in 2024 vs 16% in 2019.
▾ expand
see 5 more events →